To evaluate the association between stent dwelling time and sepsis after ureteroscopy, and identify risk factors for sepsis in this setting.
Introduction
The choice of ureteroscopy as the preferred treatment for ureteric and renal stones is continuously on the rise. Ureteroscopy is associated with a high success rate and relatively few complications, most of which are Clavien grade I or II [1, 2] . Risk factors for infectious complications after ureteroscopy have been extensively studied and include diabetes mellitus, ischaemic heart disease, female gender, high American Association of Anesthesiologists score, large stone volume, and prior drainage of the kidney [3, 4] . Between 7 and 68% of patients undergoing ureteroscopy have a ureteric stent placed before the procedure, either for emergent drainage in case of obstruction and infection or as a temporary measure for pain relief when primary treatment is not available or not possible because of other medical conditions [5, 6] . While not mandatory before every procedure, the use of ureteric stents facilitates endoscopic management of stones, improves stone-free rates, and reduces intra-operative complications [7] ; however, ureteric stents are not free of unwanted effects: flank pain, storage symptoms, haematuria and dysuria have been commonly reported. More concerning is the increased risk of UTI, which occurs in 1-7% of all ureteroscopies [1, [8] [9] [10] . Moreover, the introduction of a foreign body into the patient's urinary system increases the risk of bacterial colonization and bacteriuria, an inevitable process that begins once a stent is inserted and progresses with prolonged stent dwelling time; the majority of ureteric stents are colonized within a few weeks [11] . Nevertheless, these findings have never been translated into practical considerations.
The aim of the present study was to investigate whether preoperative stent placement increases the post-ureteroscopy sepsis rate and to evaluate the association between preoperative stent dwelling time and post-ureteroscopy sepsis rate.
Patients and Methods
After obtaining approval from the institutional ethics committee, we queried the prospectively collected ureteroscopy database of our tertiary medical centre for all patients treated for urinary stones between October 2010 and April 2016.
After stent placement, ureteroscopy was scheduled as soon as possible based on the waiting list in our public system. Urine culture was obtained before ureteroscopy in all cases. Patients were seen in an outpatient clinic 2 weeks before the intervention with a recent urine culture, obtained up to 1 month before the procedure. Those with a positive culture were treated with a full course of antibiotics for 5-7 days according to the specific pathogens identified, followed by a second culture for which results were received within 1 week of the intervention. Patients with a sterile preoperative urine culture received single-dose prophylactic i.v. antibiotics, consisting of 1 g ampicillin and 80-240 mg gentamicin, depending on the patient's renal function.
Ureteroscopy was performed using a standard technique. At the beginning of the procedure, the ureteric stent was drawn to the urethral meatus, and a wire was advanced through it to the renal pelvis. In cases of an encrusted stent, the wire was placed alongside the stent. Pressurized irrigation is used routinely with pressures of 40 and 90 mmHg for semi-rigid and flexible ureteroscopy, respectively. Lithotripsy techniques included stone dusting or stone fragmentation with removal of all fragments. The surgical technique was chosen according to surgeon preference, and performed using a laser device. After the procedure, either a ureteric catheter or a ureteric stent with or without a retrieval string were left for 1, 5, or >5 days, respectively, at the discretion of the treating surgeon. Patients were discharged on the following day.
For the present study, urosepsis was defined according to the criteria of the International Sepsis Definitions Conference of 2001, which are temperature >38°C within 48 h of surgery, in addition to one or more of the following: heart rate >90 beats/min, respiratory rate >12 breaths/min or arterial carbon dioxide pressure <32 mmHg, and white blood cell count >12 000/mm 3 or <4 000/mm 3 [12] .
The primary endpoint of the study was postoperative urosepsis within 48 h of the operation. To identify potential risk factors in the ureteroscopy cohort and specifically in patients with prior stent insertion (study cohort), the following variables were collected from the hospital's database: patient age and sex; presence of diabetes mellitus and ischaemic heart disease, age-adjusted Charlson comorbidity index (CCI), prior stent insertion, the indication for stent insertion, categorized as 'sepsis' or 'not sepsis', stent dwelling time, defined as the time from stent placement to ureteroscopy in weeks, positive preoperative urine culture, type of procedure (categorized as ureteroscopy with or without retrograde intra-renal surgery), stone size and location, access sheath utilization, operating time, postoperative drainage type and stone compostion.
Statistical Analysis
Continuous variables were described as median and interquartile range. Categorical variables were described as number and percent. The association between postoperative sepsis and patient-and procedure-related variables was evaluated with univariable and multivariable logistic regressions. All statistical analyses were two-sided. Data were analysed with SPSS statistics, version 21.0 (IBM Corp., Armonk, NY, USA). A P value of <0.05 was taken to indicate statistical significance.
Results
Between October 2010 and April 2016, 1 256 ureteroscopies were performed at our institute. Of all patients, 601 (47.8%) had a ureteric stent inserted before the operation and were included in the study cohort. Overall, there were 36 (2.8%) postoperative sepsis events. Eight and 28 occurred in nonstented and stented patients, respectively (1.2 vs 4.7%; P < 0.001). Risk factors for the development of postoperative sepsis in the ureteroscopy cohort are presented in Table 1 . On univariate logistic regression analysis, prior stent placement (odds ratio [OR] 4.54, 95% CI: 1.96-10.42; P < 0.001), female gender (OR 2.18, 95% CI: 1.11-4.28; P = 0.023), age (OR 1.02, 95% CI: 1-1.04; P = 0.042), CCI (OR 1.15, 95% CI: 1.02-1.31; P = 0.029), and operating time (OR 1.02, 95% CI: 1-1.02; P = 0.041) were associated with postureteroscopy sepsis. On multivariate logistic regression analysis adjusted for these variables, prior stent placement (OR 4.78, 95% CI: 1.95-11.76; P = 0.001), female gender (OR 2.31; 95% CI: 1.14-4.37; P = 0.02) and CCI (OR 1.15; 95% CI: 1.01-1.31; P = 0.042) remained associated with postoperative sepsis. Postoperative drainage included ureteric catheter in 169 patients (28.1%), ureteric stent with a retrieval string in 349 patients (58%), and ureteric stent without a retrieval string in 76 patients (12.6%). Stone composition was available for 318 patients (52.9%), and determined by the component that comprised ≥50% of the stone mass. Infection stones were apparent in one patient (3.6%) in the sepsis group and seven patients (1.2%) in the non-sepsis group (P = 0.37). Additional stone types and rates for patients with or without sepsis were: uric acid (14.2 vs 5.1%, P = 0.09), calcium phosphate (0 vs 2.6%; P = 1), and calcium oxalate (39.3 vs 43.5%; P = 0.19), respectively.
Sepsis rates in patients who had stents for 30, 60, 90 and >90 days before ureteroscopy were 2.2, 4.9, 5.5 and 9.2%, respectively. The infection rate was approximately five times higher in patients who had a stent for >30 days compared with patients who had a stent for <30 days (1.1 vs 6.2%; P = 0.048). Figure 1 shows the sepsis rate by stent dwelling time in weekly intervals.
On univariate logistic regression analysis, the following variables posed a higher risk of postoperative sepsis in patients with prior stent insertion: indication for stent insertion (OR 6.37; 95% CI: 2.92-13.9; P < 0.001), female gender (OR 2.6; 95% CI: 1.2-5.6; P = 0.013), CCI (OR 1.19, 95% CI: 1.01-1.34; P = 0.037), and stent dwelling time in weeks (OR 1.1; 95% CI: 1.04-1.16; P = 0.001). Urine culture status, patient age, type of operation, stone size, access sheath utilization, operating time, postoperative drainage type, and stone composition, were not significantly associated with sepsis. On multivariate logistic regression analysis, adjusted for all statistically significant variables from the univariate analyses, the indication for stent insertion (OR 4, 95% CI: 1.79-8.92; P = 0.001), female sex (OR 2.4, 95% CI: 1.08-5.36; P = 0.03), and stent dwelling time (OR 1.1, 95% CI: 1.04-1.16; P = 0.01) were associated with postoperative sepsis (Table 2) .
Discussion
In the present study we evaluated the association between preoperative stent placement and stent dwelling time and postoperative sepsis in a group of patients undergoing ureteroscopy for stone extraction. This is a matter of concern in our public medical system because of limited resources and long waiting times.
Prior stent insertion was associated with postoperative sepsis in the ureteroscopy cohort, and stent dwelling times >30 days were associated with a fivefold increase in the risk of urosepsis compared with dwelling times ≤30 days in the study cohort. In addition, female sex and sepsis as an indication for stent insertion were independent predictors of urosepsis in both cohorts.
Previous studies have shown that patients who undergo ureteric stenting prior to ureteroscopy for the treatment of urinary stones have a higher risk of infectious complications than patients treated with primary ureteroscopy [13] [14] [15] . Sohn et al. [13] conducted a retrospective study of 531 patients who underwent ureteroscopy and identified postprocedural urosepsis in 2.4-10.7% of patients, depending on the prophylactic antibiotic regimen used. On multivariate analysis, prior insertion of ureteric stents, bacteriuria and hydronephrosis were significantly associated with the occurrence of infectious complications within 1 month of surgery [13] . In a review by Grabe et al. [14] bacteriuria and prior drainage of the kidney with a ureteric stent or nephrostomy tube posed a risk of postoperative infectious complications, whereas patient age and operating time did not [14] . A retrospective study by Moses et al. [15] of 550 patients who underwent ureteroscopy showed a higher rate of infection-related hospital re-admissions in patients who had indwelling ureteric stents prior to the proceudre and longer operating time. The results of the present study are consistent with these findings, with pre-stented patients having a relatively high rate of postoperative sepsis (4.7 vs 1.2%).
Because of the questionable benefit, added costs, negative impact on quality of life and complications associated with ureteric stents, the AUA guidelines recommend against their routine placement before ureteroscopy [16] . Based on findings from retrospective studies, 16-68% of patients have a ureteric stent placed prior to the procedure [6, 7, 17, 18] . In the present study, 47.8% of the patients who underwent ureteroscopy had a ureteric stent placed before the procedure. The time between stent placement and ureteroscopy in this cohort is relatively long and variable because of the waiting lists in the public medical system. The increased risk of postoperative infection in patients with pre-placed stents was previously attributed to bacterial spread The bold was used to highlight variables that are statistically significant. CCI, Charlson comorbidity index; IQR, interquartile range; RIRS, retrograde intra-renal surgery, URS, ureteroscopy. *Remaining procedures included ureteroscopy alone.
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© 2017 The Authors BJU International © 2017 BJU International from colonized stents during their manipulation [19] . Although the correlation between this laboratory finding and clinical infection has never been established for ureteric stents, accumulating evidence shows that bacterial colonization of other foreign bodies in the urinary system, such as kidney stones and urethral catheters, is associated with an elevated risk of UTI. Thus, factors associated with stent colonization may be correlated with rates of postoperative UTI. Ureteric stent colonization has been shown to increase in patients with prolonged stent dwelling time, women and those with systemic comorbidities such as diabetes mellitus and ischaemic heart disease [20] . In a prospective study by Farsi et al. [11] , urine and stent cultures were obtained from 266 patients carrying ureteric stents for a duration of 2 weeks to 27 months. A direct association was found between the duration of stenting, bacteriuria and stent colonization, but not with patient sex. In the present study, we found that postoperative UTI rates increased with dwelling time, from 1% for a duration shorter than 1 month to 9.2% after ≥3 months. Moreover, patients with dwelling times <1 month had a fivefold lower risk of UTI compared with those with longer dwelling time, similarly to non-stented patients. The association between stent dwelling time and the rate of post-ureteroscopy sepsis has not been previously described and, if validated by future studies, may be translated to a practical recommendation to keep stent dwelling time as short as possible, preferably <1 month.
In the present study we did not find a significant association between positive preoperative urine cultures and postureteroscopy sepsis. This finding contrasts with those of several earlier studies, which found positive preoperative urine culture to be a significant predictor of postoperative sepsis in patients undergoing ureteroscopy [13, 21] . A possible explanation is that midstream urine cultures may be poor predictors of infected urine proximal to an obstructing ureteric stone [22] . Furthermore, urine cultures may not accurately represent stent colonization, possibly affecting the association between urine culture and the risk of postoperative sepsis [23] .
Few publications evaluated the correlation between the indication for stent insertion and postoperative infectious complications. Youssef et al. [24] compared the outcomes and complications of 69 patients who presented with sepsis and were treated with urgent decompression before ureteroscopy and a matched cohort who did not have sepsis and underwent primary ureteroscopy. They found that patients with sepsis had a higher overall complication rate (20 vs 7%; P = 0.007) and a higher incidence of postoperative fever (7.2 vs 0%). Paz et al. [25] noted a higher rate of fever among patients after urgent stent insertion than in patients after elective stent insertion (56 vs 6%; P < 0.001); however, they did not report the impact on post-ureteroscopy sepsis rates. In the present cohort, patients who had a stent inserted because of sepsis had a four times higher postoperative infection rate than patients without prior sepsis. This finding may be explained by the presence of a high urinary bacterial load during insertion of the stent, which increases the chances of its colonization.
Although infection stones are a well-recognized risk factor for sepsis after percutaneous nephrolithotomy, data on the risk for post-ureteroscopy sepsis in the presence of an infectious stone are lacking. Furthermore, infection stones are usually treated with percutaneous nephrolithotomy in our centre; therefore, ureteric infection stones are not commonly encountered. Stone composition was available for approximately half of the patients in the study cohort; however, no significant differences were found in the stone composition between the sepsis group and the non-sepsis group, possibly because of the small number of patients available for analyses.
The present study has several limitations. Our centre is a tertiary referral centre, therefore, some of the patients were initially treated at another hospital and referred to our centre, which may have led to selection and referral bias. Furthermore, some variables that were not recorded in our prospective database, such as stone culture and stent encrustation, could be confounding factors. One reasonable argument against the association between dwelling time and sepsis would be that patients with comorbidities may require longer time to stabilize and have greater risk of infectious complications; however, with a median dwelling time as long as 2 months it is unlikely that this was a significant factor in delaying ureteroscopy. Finally, because of the rarity of post-ureteroscopy sepsis, it is impossible to determine the exact dwelling time at which the risk of sepsis peaks, and only a general recommendation for keeping dwelling time to <1 month can be provided. Despite these limitations, the association found between stent dwelling time and postureteroscopy sepsis is novel and, if validated by future prospective trials with larger cohorts, may serve as a guide for the ideal dwelling time of ureteric stents prior to definitive therapy.
In conclusion, patients who undergo ureteroscopy after insertion of a ureteric stent have a relatively high risk of sepsis. Female gender, sepsis as an indication for stent insertion, and stent dwelling time are major contributors. In light of these results, we recommend that stent placement should be considered cautiously, and if inserted, ureteroscopy should be performed within 1 month.
